Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

JDRF and Beyond Type 1 are teaming up to support the type 1 community through education, programs, and advocacy
Approved in the US in 2018, the system stops insulin delivery when low blood sugar is predicted
The automated insulin delivery system with Dexcom’s G6 aims to launch in the US by the end of the year for those ages 14+; first system with auto boluses and no...
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...
Adam’s presentation at Friends for Life 2019
When first diagnosed, Renza was told to fear diabetes complications. This clouded her ability to do even the most basic of self-management
SGLT-2 inhibitors and GLP-1 agonists recommended as first-line therapies; Farxiga offers heart health benefits in people with and without diabetes
A trial in Boston is enrolling 168 individuals ages 65 years and older with type 1 diabetes to investigate the combination of CGM and education to reduce hypoglycemia
FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom...
Nine industry leaders share insights on better diabetes outcomes at lower costs – The diaTribe Foundation’s 4 th annual Musings Under the Moon
By Kerri Sparling Leer este artículo en español. When the ability to share my CGM data came to fruition, I was excited. And nervous. Chris and I talked briefly about...
The first ever “Closed Loop Showcase”; Ascensia’s diabetes coaching and bundled program; excitement for UnderMyFork app
A collaboration between JDRF, Stanford, and UCSF aims to cure type 1 diabetes through understanding of stem cells and the immune system
The tool for people with diabetes to use with their healthcare professionals will launch in early 2020, extending CGM further! Features include fully disposable...
As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with...
Diabetes advocates, Renza and Grumpy, share the importance of #LanguageMatters and the consequences of “grading” diabetes management
Available now to California residents, Steady Health offers remote, full-service care for type 1 or type 2 diabetes from a team of endocrinologists, nurses and care...
$99 Cash Card Program provides 3000-3800 units of any combination of Novo Nordisk analog insulins in vials or pens. NovoLog authorized generics are available at half...
Advice on how to navigate the college application process and more – here in San Francisco and on Facebook Live, July 18, 4pm-6:30pm PST
Will the medication move from “off label” to standard of care for people at high risk of developing type 2 diabetes?

Pages